Coloplast opens the week with analyst consensus, shares in Copenhagen
Published on 06/25/2026 at 19:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 17:39.
Coloplast (DK0060448595) starts Thursday with a clear analyst backdrop in Copenhagen. Investing.com pegs the consensus at Neutral, based on 21 analysts, with an average 12-month target of 458.5 DKK. Investing.com consensus page
What analysts see
The same consensus page shows 3 buy ratings, 14 hold ratings and 4 sell ratings. That split leaves the Danish medtech name in a cautious middle ground, not a one-sided call.
For retail readers, the key number is the gap between the average target and the current Copenhagen quote. The page shows a high estimate of 600 DKK and a low estimate of 345 DKK. Consensus and target range
Thursday's market frame
Thursday's angle is consensus, not a fresh corporate event. The stock sits in the Danish large-cap universe and is followed closely by analysts who publish updated target tables and rating splits.
That makes Copenhagen the local anchor for the session, with Coloplast traded on Nasdaq Copenhagen and tracked by the market for its medtech exposure. Reuters-style sector commentary is usually measured here, and the analyst table remains the most concrete live reference point.
All news and analysis on the Coloplast shares
The topic page collects Coloplast coverage, while the investor-relations page leads to company filings and reports.
Intermittent catheters and care
Coloplast makes continence, ostomy, wound care and interventional urology products. A representative product line is SpeediCath, the company's intermittent catheter range, which sits in its core urology business.
Coloplast on Nasdaq Copenhagen
The Coloplast shares (DK0060448595) trade on Nasdaq Copenhagen in Danish kroner. The latest live consensus page shows a Neutral stance, 21 analysts, and an average target of 458.5 DKK.
Key data on the Coloplast shares
- Company: Coloplast A/S
- ISIN: DK0060448595
- Ticker: COLO-B
- Trading venue: Nasdaq Copenhagen
- Sector / industry: Health Care Equipment & Supplies
- Index membership: OMX Copenhagen 20
Disclaimer: This article is for information only and does not constitute investment advice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
